Internal Medicine, Cardiovascular Disease · Olympia Fields, IL
NPI
1043203862
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3800 W 203rd St Ste 204
Olympia Fields, IL, 60461
Phone (708) 679-2670
Groups this clinician bills Medicare through
Medicare paid, 2024
$217K
5,420 services
Medicare patients, 2024
1,050
Average age 75
Drug cost, 2024
$2.9M
10,507 prescriptions
Company payments, 2025
$15K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew L Kamin was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 942 times for 602 patients. In total Matthew L Kamin billed 5,420 services in 58 codes, and Medicare paid $217K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 942 | 602 | $11.88 | $11K |
| 99214 Office E&M - Established | Office | 937 | 605 | $87.34 | $82K |
| 36415 Venipuncture Blood Collection | Office | 611 | 365 | $8.65 | $5,285 |
| 80061 Clinical Chemistry | Office | 442 | 352 | $13.10 | $5,792 |
| 93000 Electrocardiogram | Office | 305 | 297 | $9.30 | $2,837 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 296 | 74 | $5.22 | $1,545 |
| Q9956 Injection, octafluoropropane microspheres, per ml | Office | 198 | 63 | $31.32 | $6,201 |
| 93306 Echocardiography (TTE/TEE) | Office | 193 | 193 | $134.94 | $26K |
| 93356 Echocardiography (TTE/TEE) | Office | 177 | 158 | $26.00 | $4,602 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 160 | 80 | $97.07 | $16K |
| 80048 Clinical Chemistry | Office | 155 | 130 | $8.29 | $1,285 |
| 93308 Echocardiography (TTE/TEE) | Office | 118 | 98 | $65.93 | $7,780 |
| 85610 Clinical Chemistry | Office | 104 | 12 | $4.20 | $437 |
| 93015 Electrocardiogram | Office | 101 | 99 | $46.92 | $4,739 |
| 85025 Blood Count | Office | 94 | 85 | $7.61 | $715 |
By year: 2022 $261K for 4,350 services; 2023 $238K for 4,407 services; 2024 $217K for 5,420 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 611 | 365 | $8.65 | $5,285 |
| 80061 Clinical Chemistry | 442 | 352 | $13.10 | $5,792 |
| 80048 Clinical Chemistry | 155 | 130 | $8.29 | $1,285 |
| 85610 Clinical Chemistry | 104 | 12 | $4.20 | $437 |
| 85025 Blood Count | 94 | 85 | $7.61 | $715 |
| 80053 Clinical Chemistry | 80 | 77 | $10.35 | $828 |
| 83735 Clinical Chemistry | 16 | 15 | $6.34 | $101 |
| 84443 Clinical Chemistry | 14 | 14 | $16.46 | $230 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew L Kamin prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,040 prescriptions and refills. In total Matthew L Kamin wrote 10,507 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,040 | 2,871 | 330 | $15K |
| Ezetimibe Generic | 990 | 2,878 | 336 | $26K |
| Metoprolol Succinate Generic | 899 | 2,526 | 283 | $16K |
| Atorvastatin Calcium Generic | 841 | 2,382 | 280 | $12K |
| Repatha Sureclick Evolocumab | 701 | 934 | 117 | $524K |
| Carvedilol Generic | 508 | 1,411 | 163 | $5,936 |
| Xarelto Rivaroxaban | 500 | 1,132 | 132 | $616K |
| Entresto Sacubitril/Valsartan | 322 | 674 | 88 | $444K |
| Eliquis Apixaban | 307 | 673 | 88 | $388K |
| Spironolactone Generic | 285 | 799 | 98 | $1,695 |
| Lisinopril Generic | 275 | 766 | 91 | $2,516 |
| Losartan Potassium Generic | 260 | 725 | 96 | $2,330 |
| Amlodipine Besylate Generic | 255 | 747 | 95 | $2,225 |
| Furosemide Generic | 220 | 470 | 62 | $1,075 |
| Praluent Pen Alirocumab | 211 | 284 | 37 | $143K |
Brand drugs: 2,411 claims; generic drugs: 8,096 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew L Kamin $15K ($15K in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $13K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 24 | $13K |
| Novo Nordisk Inc NVO | 8 | $298 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $260 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $214 |
| Esperion Therapeutics, Inc. ESPR | 12 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $163 |
| Pfizer Inc. PFE | 8 | $159 |
| Scpharmaceuticals Inc. SCPH | 7 | $148 |
| Boston Scientific Corporation BSX | 7 | $139 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.